Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05427_nanopub.RAOuvZ1kp119jWJ2XHeLjxc91DGUkHbed9s5nPSs5Hu74#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05427 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05427 label "IDD-3 [drugbank:DB05427]" assertion.
- drugbank:DB05427 seeAlso DB05427 assertion.
- drugbank:DB05427 description "IDD-3 is a therapeutic specific immunostimulant developed by IDM Pharma in partnership with sanofi-aventis. It consists of mature dendritic cells loaded with lysates from melanoma tumor cell lines. It includes Dendritophages that are dendritic cells, a type of specialized immune cells derived from the patient's own white blood cells." assertion.
- drugbank:DB05427 identifier "drugbank:DB05427" assertion.
- drugbank:DB05427 title "IDD-3" assertion.
- drugbank:DB05427 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05427 drugbank_vocabulary:drugbank-id "DB05427" assertion.
- drugbank:DB05427 bio2rdf_vocabulary:x-identifiers.org DB05427 assertion.
- drugbank:DB05427 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05427" assertion.
- drugbank:DB05427 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05427 bio2rdf_vocabulary:identifier "DB05427" assertion.